Small molecule induces mitochondrial fusion for neuroprotection via targeting CK2 without affecting its conventional kinase activity
Open Access
- 19 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Signal Transduction and Targeted Therapy
- Vol. 6 (1), 1-13
- https://doi.org/10.1038/s41392-020-00447-6
Abstract
Mitochondrial fusion/fission dynamics plays a fundamental role in neuroprotection; however, there is still a severe lack of therapeutic targets for this biological process. Here, we found that the naturally derived small molecule echinacoside (ECH) significantly promotes mitochondrial fusion progression. ECH selectively binds to the previously uncharacterized casein kinase 2 (CK2) α′ subunit (CK2α′) as a direct cellular target, and genetic knockdown of CK2α′ abolishes ECH-mediated mitochondrial fusion. Mechanistically, ECH allosterically regulates CK2α′ conformation to recruit basic transcription factor 3 (BTF3) to form a binary protein complex. Then, the CK2α′/BTF3 complex facilitates β-catenin nuclear translocation to activate TCF/LEF transcription factors and stimulate transcription of the mitochondrial fusion gene Mfn2. Strikingly, in a mouse middle cerebral artery occlusion (MCAO) model, ECH administration was found to significantly improve cerebral injuries and behavioral deficits by enhancing Mfn2 expression in wild-type but not CK2α′+/− mice. Taken together, our findings reveal, for the first time, that CK2 is essential for promoting mitochondrial fusion in a Wnt/β-catenin-dependent manner and suggest that pharmacologically targeting CK2 is a promising therapeutic strategy for ischemic stroke.Keywords
This publication has 50 references indexed in Scilit:
- Mitochondrial ROS Signaling in Organismal HomeostasisCell, 2015
- Casein Kinase II RegulatesN-Methyl-d-Aspartate Receptor Activity in Spinal Cords and Pain Hypersensitivity Induced by Nerve InjuryThe Journal of pharmacology and experimental therapeutics, 2014
- Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular diseaseBritish Journal of Pharmacology, 2014
- Mitochondrial fission facilitates mitophagy inSaccharomyces cerevisiaeAutophagy, 2013
- Brain‐Derived Neurotrophic Factor Enhances Bcl‐xL Expression Through Protein Kinase Casein Kinase 2‐Activated and Nuclear Factor Kappa B‐Mediated Pathway in Rat HippocampusBrain Pathology, 2011
- Disruption of Fusion Results in Mitochondrial Heterogeneity and DysfunctionJournal of Biological Chemistry, 2005
- OPA1 requires mitofusin 1 to promote mitochondrial fusionProceedings of the National Academy of Sciences of the United States of America, 2004
- Axin-mediated CKI phosphorylation of β-catenin at Ser 45: a molecular switch for the Wnt pathwayGenes & Development, 2002
- Endogenous Protein Kinase CK2 Participates in Wnt Signaling in Mammary Epithelial CellsOnline Journal of Public Health Informatics, 2000
- wingless signaling acts through zeste-white 3, the drosophila homolog of glycogen synthase kinase-3, to regulate engrailed and establish cell fateCell, 1992